Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nature’s Sunshine Products, Inc. filings document the public-company record for a Nasdaq-listed Utah corporation that manufactures and markets herbal and nutritional supplements and personal care products. Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, material-event disclosures, executive appointments, compensatory arrangements, material agreements and capital-structure updates for NATR common stock.
Proxy materials cover board elections, governance practices, executive compensation, equity awards, pay-versus-performance disclosure and shareholder voting matters. The filing record also addresses risk, regulatory and business disclosures related to the company’s global wellness product operations and distribution markets.
Nature's Sunshine Products, Inc. (NATR) – Form 144 filing discloses that insider Richard D. Moss Revocable Trust intends to sell 1,000 common shares through broker Wells Fargo Clearing Services on or about 07 July 2025. Based on the reference price in the notice, the proposed transaction is valued at $15,931.15. The filing shows 18,350,801 shares outstanding; the planned sale therefore represents roughly 0.005 % of outstanding shares.
More importantly, the trust and Richard D. Moss have been active sellers during the past three months. The table included in the filing lists 18 separate transactions between 9 May 2025 and 7 July 2025, totaling 46,234 shares and generating gross proceeds of approximately $675,514. This cumulative amount equals about 0.25 % of the company’s shares outstanding. While neither the filing nor Rule 144 requires disclosure of motives, sustained insider selling can be interpreted by some investors as a signal of reduced near-term confidence or personal diversification.
The shares to be sold were originally acquired via restricted share grants and compensation on 6 May 2024; no cash outlay or special consideration was involved. The signatory certifies that no material non-public adverse information is known at the time of filing.
Takeaways for investors:
- The upcoming 1,000-share sale is immaterial in isolation, but it comes after a pattern of sizable disposals by the same beneficial owner.
- Total insider sales of >46 k shares in three months, although small relative to float, may draw attention to management’s sentiment and potential supply overhang.
- No operational or financial performance data are included; the filing is solely a notice of proposed sales under Rule 144.